BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31791394)

  • 21. Development and classes of epigenetic drugs for cancer.
    Dhanak D; Jackson P
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.
    Rafehi H; Khan AW; El-Osta A
    Expert Rev Proteomics; 2016; 13(4):435-45. PubMed ID: 26923902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic drug discovery: a success story for cofactor interference.
    Ganesan A
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of epigenetic therapies in the management of solid tumors.
    Valdespino V; Valdespino PM
    Cancer Manag Res; 2015; 7():241-51. PubMed ID: 26346546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computer- and structure-based lead design for epigenetic targets.
    Heinke R; Carlino L; Kannan S; Jung M; Sippl W
    Bioorg Med Chem; 2011 Jun; 19(12):3605-15. PubMed ID: 21316248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylation- and Methylation-Related Epigenetic Proteins in the Context of Their Targets.
    Javaid N; Choi S
    Genes (Basel); 2017 Aug; 8(8):. PubMed ID: 28783137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic therapies in haematological malignancies: searching for true targets.
    Altucci L; Minucci S
    Eur J Cancer; 2009 May; 45(7):1137-1145. PubMed ID: 19346125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment.
    Mio C; Bulotta S; Russo D; Damante G
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
    Liu K; Liu Y; Lau JL; Min J
    Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Epigenetics in Cancer.
    Bennett RL; Licht JD
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():187-207. PubMed ID: 28992434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epigenetics of schizophrenia: a review].
    Rivollier F; Lotersztajn L; Chaumette B; Krebs MO; Kebir O
    Encephale; 2014 Oct; 40(5):380-6. PubMed ID: 25127897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetics' implication in autism spectrum disorders: A review].
    Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
    Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer epigenetics: new therapies and new challenges.
    Hatzimichael E; Crook T
    J Drug Deliv; 2013; 2013():529312. PubMed ID: 23533770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease.
    Treviño LS; Wang Q; Walker CL
    Prog Biophys Mol Biol; 2015 Jul; 118(1-2):8-13. PubMed ID: 25841987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic assays for chemical biology and drug discovery.
    Gul S
    Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetics in Schistosomes: What We Know and What We Need Know.
    Liu W
    Front Cell Infect Microbiol; 2016; 6():149. PubMed ID: 27891322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.
    Drake TM; Søreide K
    Eur J Surg Oncol; 2019 May; 45(5):736-746. PubMed ID: 30745135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges.
    Gerhauser C
    Top Curr Chem; 2013; 329():73-132. PubMed ID: 22955508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.